Cidara Therapeutics (NASDAQ: CDTX) reported Q1 EPS of $0.03, $0.09 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $25.99 million versus the consensus estimate of $16.25 million.

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.